{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:21:30Z","timestamp":1790079690205,"version":"4.0.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Understanding the natural history of anal high-risk human papillomavirus (hrHPV) infection is key for designing anal cancer prevention programs but has not been systematically characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We reanalyzed data from 34 studies including 16 164 individuals in 6 risk groups defined by human immunodeficiency virus (HIV) status, sex, and male sexuality: men who have sex with men (MSM) and people with HIV (MSMWH), HIV-negative MSM, women with HIV (WWH), HIV-negative women, men who have sex with women (MSW) with HIV (MSWWH), and HIV-negative MSW. We used Markov models to estimate incidence and clearance of 13 hrHPV types and their determinants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Human papillomavirus (HPV) 16 had the highest incidence-clearance ratio of the hrHPV types. MSMWH had the highest hrHPV incidence (eg, 15.5% newly HPV-16 infected within 2 years), followed by HIV-negative MSM (7.5%), WWH (6.6%), HIV-negative women (2.9%), MSWWH (1.7%), and HIV-negative MSW (0.7%). Determinants of HPV-16 incidence included HIV status and number of sexual partners for MSM, women, and MSW, and anal sex behavior for MSM only. HPV-16 clearance was lower for people with HIV (PWH) and lower for prevalent than incident infection. Among MSM, increasing age was associated with lower clearance of prevalent, but not incident, HPV-16 infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This robust and unifying analysis of anal hrHPV natural history is essential to designing and predicting the impact of HPV vaccination and HPV-based screening programs on anal cancer prevention, particularly in MSM and PWH. Importantly, it demonstrates the higher carcinogenic potential of longstanding anal prevalent hrHPV infection than more recent incident infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciac581","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T06:19:04Z","timestamp":1658557144000},"page":"e692-e701","source":"Crossref","is-referenced-by-count":53,"title":["Incidence and Clearance of Anal Human Papillomavirus Infection in 16 164 Individuals, According to Human Immunodeficiency Virus Status, Sex, and Male Sexuality: An International Pooled Analysis of 34 Longitudinal Studies"],"prefix":"10.1093","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5868-3225","authenticated-orcid":false,"given":"Feixue","family":"Wei","sequence":"first","affiliation":[{"name":"Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC\/WHO) , Lyon , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc T","family":"Goodman","sequence":"additional","affiliation":[{"name":"Cancer Prevention and Control Program, Cedars Cancer, Cedars-Sinai Medical Center , Los Angeles, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0179-5266","authenticated-orcid":false,"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University , Xiamen, Fujian , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6601-9180","authenticated-orcid":false,"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University , Xiamen, Fujian , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna R","family":"Giuliano","sequence":"additional","affiliation":[{"name":"Center for Immunization and Infection Research in Cancer (CIIRC), Moffitt Cancer Center , Tampa, Florida , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gypsyamber","family":"D\u2019Souza","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A","family":"Hessol","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, University of California San Francisco, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten F","family":"Schim van der Loeff","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, GGD Amsterdam , Amsterdam , Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghong","family":"Dai","sequence":"additional","affiliation":[{"name":"School of Public Health, Xinjiang Medical University , Urumqi, Xinjiang , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3875-1013","authenticated-orcid":false,"given":"Karin","family":"Neukam","sequence":"additional","affiliation":[{"name":"Unidad Cl\u00ednica de Enfermedades Infecciosas y Medicina Preventiva, UCEIMP, Instituto de Biomedicina de Sevilla, CSIC, Universidad de Sevilla, Hospital Universitario Virgen del Roc\u00edo , Seville , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"de Pokomandy","sequence":"additional","affiliation":[{"name":"Chronic Viral Illness Service, McGill University Health Centre and Department of Family Medicine, McGill University , Montreal, Quebec , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I Mary","family":"Poynten","sequence":"additional","affiliation":[{"name":"The Kirby Institute, University of New South Wales , Kensington, Sydney, New South Wales , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald B","family":"Geskus","sequence":"additional","affiliation":[{"name":"Oxford University Clinical Research Unit , Ho Chi Minh City , Vietnam"},{"name":"Centre for Tropical Medicine and Global Health, University of Oxford , Oxford , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Burgos","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Universitari Vall d\u2019Hebron , Barcelona , Spain"},{"name":"Vall d\u2019Hebron Institut de Recerca (VHIR), Universitat Aut\u00f3noma de Barcelona , Barcelona , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Etienney","sequence":"additional","affiliation":[{"name":"Proctology, Diaconesses-Croix Saint Simon Hospital , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Barbara","family":"Moscicki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California , Los Angeles, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriella","family":"Don\u00e0","sequence":"additional","affiliation":[{"name":"Sexually Transmitted Infections (STI)\/HIV Unit, San Gallicano Dermatological Institute IRCCS , Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura L","family":"Gillison","sequence":"additional","affiliation":[{"name":"Thoracic Head and Neck Medical Oncology Department, University of Texas MD Anderson Cancer Center , Houston, Texas , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan G","family":"Nyitray","sequence":"additional","affiliation":[{"name":"Center for AIDS Intervention Research and Clinical Cancer Center, Medical College of Wisconsin , Milwaukee, Wisconsin , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca G","family":"Nowak","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, University of Maryland School of Medicine , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evy","family":"Yunihastuti","sequence":"additional","affiliation":[{"name":"Faculty of Medicine Universitas Indonesia\/Cipto Mangunkusumo Hospital , Jakarta , Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huachun","family":"Zou","sequence":"additional","affiliation":[{"name":"School of Public Health (Shenzhen), Sun Yat-sen University , Shenzhen , China"},{"name":"Kirby Institute, University of New South Wales , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Hidalgo-Tenorio","sequence":"additional","affiliation":[{"name":"Early Clinical Trial Unit. Biosanitary Institute (IBS.Granada). Infectious Diseases Unit. University Hospital Virgen de las Nieves , Granada , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nittaya","family":"Phanuphak","sequence":"additional","affiliation":[{"name":"Institute of HIV Research and Innovation , Bangkok , Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Molina","sequence":"additional","affiliation":[{"name":"Department of Infectious diseases, University of Paris Cit\u00e9, St-Louis Hospital , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice M","family":"Schofield","sequence":"additional","affiliation":[{"name":"Institute of Cancer Sciences, The University of Manchester , Manchester , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Kerr","sequence":"additional","affiliation":[{"name":"HIV-NAT, Thai Red Cross AIDS Research Centre, and Research Affairs, Faculty of Medicine, Chulalongkorn University , Bangkok , Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Fan","sequence":"additional","affiliation":[{"name":"School of Public Health, Southwest Medical University , Luzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Lu","sequence":"additional","affiliation":[{"name":"School of Public Health, the Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University , Guiyang , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason J","family":"Ong","sequence":"additional","affiliation":[{"name":"Central Clinical School, Monash University , Melbourne , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Admire T","family":"Chikandiwa","sequence":"additional","affiliation":[{"name":"Wits RHI, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg , South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirinya","family":"Teeraananchai","sequence":"additional","affiliation":[{"name":"Department of Statistics, Faculty of Science, Kasetsart University , Bangkok , Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Squillace","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit ASST-Monza, San Gerardo Hospital-University of Milano-Bicocca , Monza , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy J","family":"Wiley","sequence":"additional","affiliation":[{"name":"School of Nursing, University of California , Los Angeles, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M","family":"Palefsky","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California , San Francisco, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Georges","sequence":"additional","affiliation":[{"name":"Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC\/WHO) , Lyon , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina J","family":"Alberts","sequence":"additional","affiliation":[{"name":"Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC\/WHO) , Lyon , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7534-333X","authenticated-orcid":false,"given":"Gary M","family":"Clifford","sequence":"additional","affiliation":[{"name":"Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC\/WHO) , Lyon , France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,23]]},"reference":[{"key":"2023052918455690400_ciac581-B1","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2023052918455690400_ciac581-B2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ijc.33185","article-title":"A meta-analysis of anal cancer incidence by risk group: toward a unified anal cancer risk scale","volume":"148","author":"Clifford","year":"2021","journal-title":"Int J Cancer"},{"key":"2023052918455690400_ciac581-B3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1473-3099(17)30653-9","article-title":"Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis","volume":"18","author":"Lin","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2023052918455690400_ciac581-B4","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/cid\/ciy738","article-title":"Incidence and clearance of anal high-risk human papillomavirus infections and their determinants over 5 years among Human Immunodeficiency virus-negative men who have sex with men","volume":"68","author":"Marra","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023052918455690400_ciac581-B5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/QAD.0000000000000909","article-title":"The effect of HIV infection on anal and penile human papillomavirus incidence and clearance: a cohort study among MSM","volume":"30","author":"Mooij","year":"2016","journal-title":"AIDS"},{"key":"2023052918455690400_ciac581-B6","doi-asserted-by":"crossref","first-page":"100187","DOI":"10.1016\/j.pvr.2019.100187","article-title":"Estimating incidence rates of grouped HPV types: a systematic review and comparison of the impact of different epidemiological assumptions","volume":"8","author":"Jongen","year":"2019","journal-title":"Papillomavirus Res"},{"key":"2023052918455690400_ciac581-B7","author":"Jackson","year":"2021"},{"key":"2023052918455690400_ciac581-B8","first-page":"1","article-title":"Biological agents. Volume 100B. A review of human carcinogens","volume":"100(pt B)","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"2012","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"2023052918455690400_ciac581-B9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/QAD.0000000000000874","article-title":"Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors","volume":"30","author":"Geskus","year":"2016","journal-title":"AIDS"},{"key":"2023052918455690400_ciac581-B10","doi-asserted-by":"crossref","first-page":"1004 e1","DOI":"10.1016\/j.cmi.2016.08.011","article-title":"Anal human papillomavirus in HIV-uninfected men who have sex with men: incidence and clearance rates, duration of infection, and risk factors","volume":"22","author":"Dona","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2023052918455690400_ciac581-B11","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/infdis\/jiy556","article-title":"Type-Specific anal human papillomavirus prevalence among men, according to sexual preference and HIV status: a systematic literature review and meta-analysis","volume":"219","author":"Marra","year":"2019","journal-title":"J Infect Dis"},{"key":"2023052918455690400_ciac581-B12","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.1016\/S2352-3018(21)00108-9","article-title":"Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies","volume":"8","author":"Wei","year":"2021","journal-title":"Lancet HIV"},{"key":"2023052918455690400_ciac581-B13","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/516784","article-title":"A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion","volume":"195","author":"Plummer","year":"2007","journal-title":"J Infect Dis"},{"key":"2023052918455690400_ciac581-B14","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/infdis\/jiz623","article-title":"Incidence and clearance of anal human papillomavirus (HPV)-16 and HPV-18 infection, and their determinants, among human immunodeficiency virus-infected men who have sex with men in France","volume":"221","author":"Alberts","year":"2020","journal-title":"J Infect Dis"},{"key":"2023052918455690400_ciac581-B15","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ijc.24752","article-title":"Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology","volume":"126","author":"Maucort-Boulch","year":"2010","journal-title":"Int J Cancer"},{"key":"2023052918455690400_ciac581-B16","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/cid\/ciaa166","article-title":"The natural history of anal high-grade squamous intraepithelial lesions in gay and bisexual men","volume":"72","author":"Poynten","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023052918455690400_ciac581-B17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/cncr.20365","article-title":"Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer","volume":"101","author":"Daling","year":"2004","journal-title":"Cancer"},{"key":"2023052918455690400_ciac581-B18","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.3201\/eid2610.191646","article-title":"Sequential acquisition of human papillomavirus infection at genital and anal sites, liuzhou, China","volume":"26","author":"Wei","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"2023052918455690400_ciac581-B19","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/infdis\/jiw334","article-title":"Sequential acquisition of anal human papillomavirus (HPV) infection following genital infection among men who have sex with women: the HPV Infection in Men (HIM) study","volume":"214","author":"Pamnani","year":"2016","journal-title":"J Infect Dis"},{"key":"2023052918455690400_ciac581-B20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.canep.2016.04.001","article-title":"Front-to-back & dabbing wiping behaviour post-toilet associated with anal neoplasia & HR-HPV carriage in women with previous HPV-mediated gynaecological neoplasia","volume":"42","author":"Simpson S","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"2023052918455690400_ciac581-B21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/cid\/cit947","article-title":"Natural history of anal human papillomavirus infection in heterosexual women and risks associated with persistence","volume":"58","author":"Moscicki","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2023052918455690400_ciac581-B22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41598-021-03913-5","article-title":"Incidence and clearance of anal high-risk human papillomavirus infection and their risk factors in men who have sex with men living with HIV","volume":"12","author":"Don\u00e0","year":"2022","journal-title":"Sci Rep"},{"key":"2023052918455690400_ciac581-B23","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S1473-3099(20)30687-3","article-title":"Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study","volume":"21","author":"Chow","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2023052918455690400_ciac581-B24","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S2468-2667(16)30001-9","article-title":"Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models","volume":"1","author":"Brisson","year":"2016","journal-title":"Lancet Public Health"},{"key":"2023052918455690400_ciac581-B25","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N Engl J Med"},{"key":"2023052918455690400_ciac581-B26","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S1470-2045(11)70213-3","article-title":"Efficacy of a bivalent HPV 16\/18 vaccine against anal HPV 16\/18 infection among young women: a nested analysis within the Costa Rica vaccine trial","volume":"12","author":"Kreimer","year":"2011","journal-title":"Lancet Oncol"},{"key":"2023052918455690400_ciac581-B27","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.vaccine.2019.11.081","article-title":"Human papillomavirus vaccination coverage, policies, and practical implementation across Europe","volume":"38","author":"Nguyen-Huu","year":"2020","journal-title":"Vaccine"},{"key":"2023052918455690400_ciac581-B28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/v13020144","article-title":"Effectiveness of the quadrivalent HPV vaccine in preventing anal \u2265 HSILs in a Spanish population of HIV+ MSM aged &gt; 26 years","volume":"13","author":"Hidalgo-Tenorio","year":"2021","journal-title":"Viruses"},{"key":"2023052918455690400_ciac581-B29","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/cid\/ciy274","article-title":"A randomized, placebo-controlled trial of the quadrivalent human papillomavirus vaccine in human immunodeficiency virus-infected adults aged 27 years or older: AIDS clinical trials group protocol A5298","volume":"67","author":"Wilkin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2023052918455690400_ciac581-B30","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2201048","article-title":"Treatment of anal high-grade squamous intraepithelial lesions to prevent anal cancer","volume":"386","author":"Palefsky","year":"2022","journal-title":"N Engl J Med"},{"key":"2023052918455690400_ciac581-B31","first-page":"jiac108","article-title":"Age-specific prevalence of anal and cervical HPV infection and high-grade lesions in 11 177 women by HIV status: a collaborative pooled analysis of 26 studies","author":"Wei","year":"2022","journal-title":"J Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac581\/45275365\/ciac581.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/3\/e692\/50482778\/ciac581.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/3\/e692\/50482778\/ciac581.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T14:46:29Z","timestamp":1685371589000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/76\/3\/e692\/6649069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,23]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,7,23]]},"published-print":{"date-parts":[[2023,2,8]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac581","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742248316.793594421","asserted-by":"object"}]},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2022,7,23]]}}}